Literature DB >> 19789335

Mutant p53 disrupts the stress MAPK activation circuit induced by ASK1-dependent stabilization of Daxx.

Tetsuya Kitamura1, Yayoi Fukuyo, Masahiro Inoue, Nobuko T Horikoshi, Masanobu Shindoh, Buck E Rogers, Anny Usheva, Nobuo Horikoshi.   

Abstract

Daxx is a regulatory protein for apoptosis signal-regulating kinase 1 (ASK1) which activates c-Jun NH2-terminal kinase (JNK) and p38 pathways in response to stressors such as tumor necrosis factor-alpha (TNFalpha). Here, we show that TNFalpha treatment induces the accumulation of Daxx protein through ASK1 activation by preventing its proteasome-dependent degradation. ASK1 directly phosphorylates Daxx at Ser(176) and Ser(184) and Daxx is required for the sustained activation of JNK. Tumorigenic mutant p53, which binds to Daxx and inhibits Daxx-dependent activation of ASK1, prevents Daxx phosphorylation and stabilization. When mutant p53 was depleted in cancer cells, Daxx was accumulated and the cell-killing effect of TNFalpha was restored. Our results indicate that Daxx not only activates ASK1 but also is a downstream target of ASK1 and that accumulated Daxx further activates ASK1. Thus, the Daxx-ASK1 positive feedback loop amplifying JNK/p38 signaling plays an important role in the cell-killing effects of stressors, such as TNFalpha. Tumorigenic mutant p53 disrupts this circuit and makes cells more tolerable to stresses, as its gain-of-function mechanism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19789335      PMCID: PMC2855193          DOI: 10.1158/0008-5472.CAN-09-2133

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  35 in total

1.  SCF ubiquitin protein ligases and phosphorylation-dependent proteolysis.

Authors:  A R Willems; T Goh; L Taylor; I Chernushevich; A Shevchenko; M Tyers
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-09-29       Impact factor: 6.237

2.  Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53.

Authors:  S Fang; J P Jensen; R L Ludwig; K H Vousden; A M Weissman
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

3.  A suppressive role of the prolyl isomerase Pin1 in cellular apoptosis mediated by the death-associated protein Daxx.

Authors:  Akihide Ryo; Akiko Hirai; Mayuko Nishi; Yih-Cherng Liou; Kilian Perrem; Sheng-Cai Lin; Hisashi Hirano; Sam W Lee; Ichiro Aoki
Journal:  J Biol Chem       Date:  2007-10-15       Impact factor: 5.157

4.  Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway.

Authors:  C Tournier; P Hess; D D Yang; J Xu; T K Turner; A Nimnual; D Bar-Sagi; S N Jones; R A Flavell; R J Davis
Journal:  Science       Date:  2000-05-05       Impact factor: 47.728

5.  ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis.

Authors:  K Tobiume; A Matsuzawa; T Takahashi; H Nishitoh; K Morita ; K Takeda; O Minowa; K Miyazono; T Noda; H Ichijo
Journal:  EMBO Rep       Date:  2001-03       Impact factor: 8.807

6.  Inhibition of Daxx-mediated apoptosis by heat shock protein 27.

Authors:  S J Charette; J N Lavoie; H Lambert; J Landry
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

7.  PUMA is directly activated by NF-kappaB and contributes to TNF-alpha-induced apoptosis.

Authors:  P Wang; W Qiu; C Dudgeon; H Liu; C Huang; G P Zambetti; J Yu; L Zhang
Journal:  Cell Death Differ       Date:  2009-05-15       Impact factor: 15.828

8.  The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss.

Authors:  Tamara Terzian; Young-Ah Suh; Tomoo Iwakuma; Sean M Post; Manja Neumann; Gene A Lang; Carolyn S Van Pelt; Guillermina Lozano
Journal:  Genes Dev       Date:  2008-05-15       Impact factor: 11.361

9.  Homeodomain-interacting protein kinase 1 modulates Daxx localization, phosphorylation, and transcriptional activity.

Authors:  Jeffrey A Ecsedy; Jennifer S Michaelson; Philip Leder
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

10.  Structural and functional characterization of the human protein kinase ASK1.

Authors:  Gabor Bunkoczi; Eidarus Salah; Panagis Filippakopoulos; Oleg Fedorov; Susanne Müller; Frank Sobott; Sirlester A Parker; Haifeng Zhang; Wang Min; Benjamin E Turk; Stefan Knapp
Journal:  Structure       Date:  2007-10       Impact factor: 5.006

View more
  7 in total

1.  Subcellular localization of DAXX influence ox-LDL induced apoptosis in macrophages.

Authors:  Guozuo Xiong; Lin Li; Shaowei Sun; Tianping Li; Duanfang Liao; Chang Shu; Qinhui Tuo
Journal:  Mol Biol Rep       Date:  2014-08-14       Impact factor: 2.316

2.  Oncogenic pathways activated by pro-inflammatory cytokines promote mutant p53 stability: clue for novel anticancer therapies.

Authors:  Gabriella D'Orazi; Marco Cordani; Mara Cirone
Journal:  Cell Mol Life Sci       Date:  2020-10-17       Impact factor: 9.261

3.  The gain of function of p53 cancer mutant in promoting mammary tumorigenesis.

Authors:  X Lu; D P Liu; Y Xu
Journal:  Oncogene       Date:  2012-07-23       Impact factor: 9.867

4.  Apigenin enhances the cisplatin cytotoxic effect through p53-modulated apoptosis.

Authors:  Rui Liu; Ping Ji; Bin Liu; Haishi Qiao; Xia Wang; Likun Zhou; Ting Deng; Yi Ba
Journal:  Oncol Lett       Date:  2016-12-14       Impact factor: 2.967

5.  Apolipoprotein E4 Elicits Lysosomal Cathepsin D Release, Decreased Thioredoxin-1 Levels, and Apoptosis.

Authors:  Torbjörn Persson; Francesca Lattanzio; Javier Calvo-Garrido; Roberto Rimondini; Marta Rubio-Rodrigo; Erik Sundström; Silvia Maioli; Anna Sandebring-Matton; Ángel Cedazo-Mínguez
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 6.  DAXX in cancer: phenomena, processes, mechanisms and regulation.

Authors:  Iqbal Mahmud; Daiqing Liao
Journal:  Nucleic Acids Res       Date:  2019-09-05       Impact factor: 16.971

Review 7.  Understanding MAPK Signaling Pathways in Apoptosis.

Authors:  Jicheng Yue; José M López
Journal:  Int J Mol Sci       Date:  2020-03-28       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.